Heron Therapeutics Inc vs Health Care Select Sector SPDR Fund — how do they compare? Heron Therapeutics Inc trades at $0.33 (market cap $61.47M), while Health Care Select Sector SPDR Fund trades at $166.92. The key difference: Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| HRTX | XLV | |
|---|---|---|
Market Cap | $61.47M | — |
Sector | Health | — |
52-Week High | $1.49 | $168.44 |
52-Week Low | $0.32 | $131.16 |
Enterprise Value | $168.21M | — |
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →